Cybin Announces Poster Presentation at Neuroscience 2023 Annual Meeting

TORONTO, November 15, 2023--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced a poster presentation at Neuroscience 2023 hosted by the Society for Neuroscience ("SFN") taking place November 11-15, 2022, in Washington, D.C.

Related Keywords

Washington ,United States ,Netherlands ,United Kingdom ,Toronto ,Ontario ,Canada ,Ireland ,American ,Clintone Canal ,Michaele Morgan ,Pradip Pathare ,Richa Tyagi ,Erik Stang ,Joshuaa Hartsel ,Gabriel Fahel ,Geoff Varty ,Geoffreyb Varty ,Amyc Reichelt ,Alex Nivorozhkin ,Ken Avery ,Tinaa Mueller ,Michaelg Palfreyman ,Youtube ,Exchange Commission ,Society For Neuroscience ,Head Of Research Development At Cybin ,Cybin Inc ,Neither The Neo Exchange Inc ,Instagram ,Drug Administration ,Linkedin ,Health Canada ,Mood Disorder ,Neo Exchange ,Media Contact ,The Company ,Iopharmaceutical Company ,Mental Healthcare ,Cybin ,Forward Looking Statements ,Herapeutics ,Company ,